BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu CS, Yen CJ, Chou RH, Li ST, Huang WC, Ren CT, Wu CY, Yu YL. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. PLoS One 2012;7:e39466. [PMID: 22808038 DOI: 10.1371/journal.pone.0039466] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wu C, Chang S. DISCOVERIES AND APPLICATIONS OF GLYCAN ARRAYS. In: Hung S, Zulueta MML, editors. Glycochemical Synthesis. Hoboken: John Wiley & Sons, Inc.; 2016. pp. 407-24. [DOI: 10.1002/9781119006435.ch15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Chen CT, Liao WY, Hsu CC, Hsueh KC, Yang SF, Teng YH, Yu YL. FUT2 genetic variants as predictors of tumor development with hepatocellular carcinoma. Int J Med Sci 2017;14:885-90. [PMID: 28824326 DOI: 10.7150/ijms.19734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Lee MJ, Na K, Jeong SK, Lim JS, Kim SA, Lee MJ, Song SY, Kim H, Hancock WS, Paik YK. Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma. J Proteome Res 2014;13:4878-88. [PMID: 25057901 DOI: 10.1021/pr5002719] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
4 Purohit S, Ferris DG, Alvarez M, Tran PMH, Tran LKH, Mysona DP, Hopkins D, Zhi W, Dun B, Wallbillich JJ, Cummings RD, Wang PG, She JX. Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy. Gynecol Oncol 2020;157:181-7. [PMID: 31955861 DOI: 10.1016/j.ygyno.2020.01.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Russo D, Capolupo L, Loomba JS, Sticco L, D'Angelo G. Glycosphingolipid metabolism in cell fate specification. J Cell Sci 2018;131:jcs219204. [PMID: 30559216 DOI: 10.1242/jcs.219204] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
6 He D, Wang D, Shi X, Quan W, Xiong R, Yu C, Huang H. Simultaneous fluorescence analysis of the different carbohydrates expressed on living cell surfaces using functionalized quantum dots. RSC Adv 2017;7:12374-81. [DOI: 10.1039/c6ra27612a] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
7 Saad F, Gadallah M, Daif A, Bedair N, Sakr MA. Heparanase (HPSE) gene polymorphism (rs12503843) contributes as a risk factor for hepatocellular carcinoma (HCC): a pilot study among Egyptian patients. J Genet Eng Biotechnol 2021;19:3. [PMID: 33411145 DOI: 10.1186/s43141-020-00106-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Muthana SM, Gildersleeve JC. Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum. Sci Rep 2016;6:19509. [PMID: 26781493 DOI: 10.1038/srep19509] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
9 Park S, Gildersleeve JC, Blixt O, Shin I. Carbohydrate microarrays. Chem Soc Rev 2013;42:4310-26. [PMID: 23192235 DOI: 10.1039/c2cs35401b] [Cited by in Crossref: 189] [Cited by in F6Publishing: 62] [Article Influence: 18.9] [Reference Citation Analysis]
10 Deng L, Chen X, Varki A. Exploration of sialic acid diversity and biology using sialoglycan microarrays. Biopolymers 2013;99:650-65. [PMID: 23765393 DOI: 10.1002/bip.22314] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
11 Sugiyama Y, Katoh T, Honda Y, Gotoh A, Ashida H, Kurihara S, Yamamoto K, Katayama T. Application study of 1,2-α-l-fucosynthase: introduction of Fucα1-2Gal disaccharide structures on N-glycan, ganglioside, and xyloglucan oligosaccharide. Biosci Biotechnol Biochem 2017;81:283-91. [PMID: 27832720 DOI: 10.1080/09168451.2016.1254532] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
12 Daniotti JL, Vilcaes AA, Torres Demichelis V, Ruggiero FM, Rodriguez-Walker M. Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches. Front Oncol 2013;3:306. [PMID: 24392350 DOI: 10.3389/fonc.2013.00306] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
13 Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Int J Cancer. 2014;134:1638-1647. [PMID: 24122375 DOI: 10.1002/ijc.28501] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
14 Restuccia A, Fettis MM, Hudalla GA. Glycomaterials for immunomodulation, immunotherapy, and infection prophylaxis. J Mater Chem B 2016;4:1569-85. [DOI: 10.1039/c5tb01780g] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kočevar N, Hudler P, Komel R. The progress of proteomic approaches in searching for cancer biomarkers. New Biotechnology 2013;30:319-26. [DOI: 10.1016/j.nbt.2012.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
16 Yiang GT, Chou PL, Hung YT, Chen JN, Chang WJ, Yu YL, Wei CW. Vitamin C enhances anticancer activity in methotrexatetreated Hep3B hepatocellular carcinoma cells. Oncol Rep. 2014;32:1057-1063. [PMID: 24969544 DOI: 10.3892/or.2014.3289] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
17 Jiang YY, Zheng SJ. Progress in research of sphingolipids in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2018; 26(36): 2109-2114 [DOI: 10.11569/wcjd.v26.i36.2109] [Reference Citation Analysis]
18 Tanaka-Okamoto M, Yabu M, Mukai M, Takahashi H, Fujiwara Y, Ohue M, Kamada Y, Miyoshi E, Miyamoto Y. Elevation of CA19-9-Related Novel Marker, Core 1 Sialyl Lewis A, in Sera of Adenocarcinoma Patients Verified by a SRM-Based Method. J Proteome Res 2016;15:152-65. [PMID: 26641888 DOI: 10.1021/acs.jproteome.5b00893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Herbáth M, Papp K, Balogh A, Matkó J, Prechl J. Exploiting fluorescence for multiplex immunoassays on protein microarrays. Methods Appl Fluoresc 2014;2:032001. [PMID: 29148470 DOI: 10.1088/2050-6120/2/3/032001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
20 Yu YL, Yiang GT, Chou PL, Tseng HH, Wu TK, Hung YT, Lin PS, Lin SY, Liu HC, Chang WJ, Wei CW. Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation. Mol Med Rep 2014;9:2077-84. [PMID: 24682227 DOI: 10.3892/mmr.2014.2085] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
21 Hsieh MC, Hsu HT, Hsiao PC, Yang SF, Yeh CB, Bien MY, Lin CH, Chien MH. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development. J Clin Lab Anal 2014;28:237-44. [PMID: 24478168 DOI: 10.1002/jcla.21672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kim SH, Lee MJ, Hwang HK, Lee SH, Kim H, Paik Y, Kang CM. Prognostic potential of the preoperative plasma complement factor B in resected pancreatic cancer: A pilot study. CBM 2019;24:335-42. [DOI: 10.3233/cbm-181847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
23 Chen DR, Chuang CY, Wu BC, Yang SF, Peng YH, Tsai HT. Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer. J Clin Lab Anal 2014;28:287-93. [PMID: 24578158 DOI: 10.1002/jcla.21682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Groux-Degroote S, Delannoy P. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy. Int J Mol Sci 2021;22:6145. [PMID: 34200284 DOI: 10.3390/ijms22116145] [Reference Citation Analysis]
25 Smorodin E, Sergeyev B, Kurtenkov O, Kuznetsova T, Geller J. IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment. Dis Markers 2018;2018:4639805. [PMID: 30627223 DOI: 10.1155/2018/4639805] [Reference Citation Analysis]
26 Muthana SM, Xia L, Campbell CT, Zhang Y, Gildersleeve JC. Competition between serum IgG, IgM, and IgA anti-glycan antibodies. PLoS One 2015;10:e0119298. [PMID: 25807519 DOI: 10.1371/journal.pone.0119298] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
27 Lin CW, Chuang CY, Tang CH, Chang JL, Lee LM, Lee WJ, Chow JM, Yang SF, Chien MH. Combined effects of icam-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development. PLoS One 2013;8:e72940. [PMID: 24069166 DOI: 10.1371/journal.pone.0072940] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
28 Chang SL, Chou RH, Zeng HJ, Lin YH, Chiu TY, Yang DM, Hung SC, Lai CH, Hsieh JT, Shyu WC, Yu YL. Downregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells. PLoS One 2013;8:e75884. [PMID: 24073285 DOI: 10.1371/journal.pone.0075884] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
29 Chang SL, Chen SY, Huang HH, Ko HA, Liu PT, Liu YC, Chen PH, Liu FC. Ectopic expression of nolz-1 in neural progenitors promotes cell cycle exit/premature neuronal differentiation accompanying with abnormal apoptosis in the developing mouse telencephalon. PLoS One 2013;8:e74975. [PMID: 24073229 DOI: 10.1371/journal.pone.0074975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
30 Sheu MJ, Hsieh MJ, Chiang WL, Yang SF, Lee HL, Lee LM, Yeh CB. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma. PLoS One 2015;10:e0122961. [PMID: 25860955 DOI: 10.1371/journal.pone.0122961] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
31 Huang HL, Hsieh MJ, Chien MH, Chen HY, Yang SF, Hsiao PC. Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells. PLoS One 2014;9:e98943. [PMID: 24901249 DOI: 10.1371/journal.pone.0098943] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
32 Yu YL, Su KJ, Hsieh MJ, Wang SS, Wang PH, Weng WC, Yang SF. Impact of EZH2 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic features. PLoS One 2014;9:e93635. [PMID: 24691023 DOI: 10.1371/journal.pone.0093635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
33 Zacco E, Anish C, Martin CE, v. Berlepsch H, Brandenburg E, Seeberger PH, Koksch B. A Self-Assembling Peptide Scaffold for the Multivalent Presentation of Antigens. Biomacromolecules 2015;16:2188-97. [DOI: 10.1021/acs.biomac.5b00572] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
34 Emokpae MA, Adejumol BG, Abdu A, Sadiq NM. Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients. Niger Med J 2013;54:426-9. [PMID: 24665160 DOI: 10.4103/0300-1652.126302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Wu CS, Lee TY, Chou RH, Yen CJ, Huang WC, Wu CY, Yu YL. Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma. PLoS One. 2014;9:e99959. [PMID: 24927126 DOI: 10.1371/journal.pone.0099959] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
36 Tsai HT, Hsieh MJ, Chiou HL, Lee HL, Hsin MC, Liou YS, Yang CC, Yang SF, Kuo WH. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women. Tumour Biol 2014;35:8999-9007. [PMID: 24903383 DOI: 10.1007/s13277-014-2170-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wang SS, Liu YF, Ou YC, Chen CS, Li JR, Yang SF. Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan. PLoS One 2013;8:e82804. [PMID: 24349364 DOI: 10.1371/journal.pone.0082804] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
38 Chou YE, Hsieh MJ, Chiou HL, Lee HL, Yang SF, Chen TY. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features. Biomed Res Int 2014;2014:231474. [PMID: 24971320 DOI: 10.1155/2014/231474] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
39 Lamarre M, Tremblay T, Bansept MA, Robitaille K, Fradet V, Giguère D, Boudreau D. A glycan-based plasmonic sensor for prostate cancer diagnosis. Analyst 2021;146:6852-60. [PMID: 34623365 DOI: 10.1039/d1an00789k] [Reference Citation Analysis]